Alumni adventures: Catching up with student intern Daniel Million

Million reflects on how a summer internship at Sanford Burnham Prebys accelerated his scientific career.

Fighting rare diseases: Finding treatments and bringing hope to families

Two patients whose lives were saved by discoveries made by Hudson Freeze, Ph.D., and José Luis Millán, Ph.D., joined the scientists for a conversation about what this work means to them and how their lives have been impacted.

Starving tumors by blocking glutamine uptake

Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a drug candidate that blocks the uptake of glutamine, a key food source for many tumors, and slows the growth of melanoma.

Could low-cost leprosy drug clofazimine be repurposed for COVID-19?

Scientists pointed to clofazimine, a low-cost leprosy drug first approved by the FDA in 1986, as a possible COVID-19 drug after finding promising anti-coronavirus activity in hamsters.

Decades-Old Leprosy Drug Inhibits Coronaviruses, May Treat COVID-19

In an effort to find new treatments for COVID-19 that could be made available quickly, researchers searched through FDA-approved drugs to identify candidates that may inhibit SARS-CoV-2 replication. Researchers found that a decades-old anti-leprosy drug exhibits potent antiviral activities against many coronaviruses—including SARS-CoV-2.